Literature DB >> 15563892

Mutations profile in Chinese patients with hypertrophic cardiomyopathy.

Lei Song1, Yubao Zou, Jizheng Wang, Zhimin Wang, Yisong Zhen, Kejia Lou, Qian Zhang, Xiaojian Wang, Hu Wang, Jia Li, Rutai Hui.   

Abstract

BACKGROUND: There are more than 1 million patients with hypertrophic cardiomyopathy (HCM) in China, but the genetic basis is presently unknown.
METHODS: We investigated 100 independent patients with HCM (proband 51, sporadic 49) by sequencing the three most frequent HCM-causing genes (MYH7, MYBPC3, TNNT2).
RESULTS: Thirty-four patients (34%) carried 25 types of mutations in the selected genes, most (14/25) were newly identified. MYH7 and MYBPC3 accounted for 41% and 18% of the familial HCM, respectively. TNNT2 mutations only caused 2% of the familial HCM. These results suggested that MYH7 and MYBPC3 were the predominant genes responsible for HCM, and TNNT2 mutation less proportionally contributed to Chinese HCM. MYH7 mutations caused HCM at younger age, more frequent syncope and ECG abnormalities compared with MYBPC3 mutations. The patients carrying R663C, Q734P, E930K in MYH7 and R130C in TNNT2 expressed malignant phenotype. R403Q in MYH7, the most common hot and malignant mutation in Caucasians, was not identified in Chinese.
CONCLUSION: We confirmed the diversity of mutation profile in different populations and suggest that a global registry of HCM mutations and their phenotypes is necessary to correlate genotype with phenotype.

Entities:  

Mesh:

Year:  2005        PMID: 15563892     DOI: 10.1016/j.cccn.2004.09.016

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  20 in total

1.  A low prevalence of MYH7/MYBPC3 mutations among familial hypertrophic cardiomyopathy patients in India.

Authors:  Murali D Bashyam; Guroji Purushotham; Ajay K Chaudhary; Katika Madhumohan Rao; Vishal Acharya; Tabrez A Mohammad; Hampapathalu A Nagarajaram; Vuppaladadhiam Hariram; Calambur Narasimhan
Journal:  Mol Cell Biochem       Date:  2011-09-29       Impact factor: 3.396

2.  Multidimensional structure-function relationships in human β-cardiac myosin from population-scale genetic variation.

Authors:  Julian R Homburger; Eric M Green; Colleen Caleshu; Margaret S Sunitha; Rebecca E Taylor; Kathleen M Ruppel; Raghu Prasad Rao Metpally; Steven D Colan; Michelle Michels; Sharlene M Day; Iacopo Olivotto; Carlos D Bustamante; Frederick E Dewey; Carolyn Y Ho; James A Spudich; Euan A Ashley
Journal:  Proc Natl Acad Sci U S A       Date:  2016-05-31       Impact factor: 11.205

3.  Practice viewpoints: AICD, who and when?

Authors:  R J Sung; N-Y Chan
Journal:  Heart Asia       Date:  2009-01-01

4.  Prognostic predictive value of gene mutations in Japanese patients with hypertrophic cardiomyopathy.

Authors:  Ayako Chida; Kei Inai; Hiroki Sato; Eriko Shimada; Tsutomu Nishizawa; Mitsuyo Shimada; Michiko Furutani; Yoshiyuki Furutani; Yoichi Kawamura; Masaya Sugimoto; Jun Ishihara; Masako Fujiwara; Takashi Soga; Masatoshi Kawana; Shinya Fuji; Shigeru Tateno; Kenji Kuraishi; Shigetoyo Kogaki; Mitsuhiro Nishimura; Mamoru Ayusawa; Fukiko Ichida; Hirokuni Yamazawa; Rumiko Matsuoka; Shigeaki Nonoyama; Toshio Nakanishi
Journal:  Heart Vessels       Date:  2016-11-24       Impact factor: 2.037

5.  Angiotensinogen gene variations and LV outflow obstruction in hypertrophic cardiomyopathy.

Authors:  S Wang; J Wang; Y Zou; J Wang; H Wang; R Hui
Journal:  Herz       Date:  2013-07-25       Impact factor: 1.443

6.  Estimate of the abundance of cardiomyopathic mutations in the β-myosin gene.

Authors:  Micah Hamady; Massimo Buvoli; Leslie A Leinwand; Rob Knight
Journal:  Int J Cardiol       Date:  2009-01-26       Impact factor: 4.164

7.  Mutation of junctophilin type 2 associated with hypertrophic cardiomyopathy.

Authors:  Yoshihisa Matsushita; Toru Furukawa; Hiroshi Kasanuki; Makoto Nishibatake; Yachiyo Kurihara; Atsushi Ikeda; Naoyuki Kamatani; Hiroshi Takeshima; Rumiko Matsuoka
Journal:  J Hum Genet       Date:  2007-05-03       Impact factor: 3.172

8.  Hypertrophic cardiomyopathy family with double-heterozygous mutations; does disease severity suggest doubleheterozygosity?

Authors:  I A W van Rijsingen; J F Hermans-van Ast; Y H J M Arens; S M Schalla; C E M de Die-Smulders; A van den Wijngaard; Y M Pinto
Journal:  Neth Heart J       Date:  2009-12       Impact factor: 2.380

9.  Alternative exon 9-encoded relay domains affect more than one communication pathway in the Drosophila myosin head.

Authors:  Marieke J Bloemink; Corey M Dambacher; Aileen F Knowles; Girish C Melkani; Michael A Geeves; Sanford I Bernstein
Journal:  J Mol Biol       Date:  2009-04-22       Impact factor: 5.469

Review 10.  Cardiac troponin structure-function and the influence of hypertrophic cardiomyopathy associated mutations on modulation of contractility.

Authors:  Yuanhua Cheng; Michael Regnier
Journal:  Arch Biochem Biophys       Date:  2016-02-04       Impact factor: 4.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.